Dr. Ronghua Jin | Drug Delivery System | Best Researcher Award

Dr. Ronghua Jin | Drug Delivery System | Best Researcher Award

Dr. Ronghua Jin, Guangxi Medical University, China

Dr. Ronghua Jin is a distinguished researcher in nanomedicine, drug delivery systems, and cancer therapy. He earned his Ph.D. in Chemical Engineering from Xi’an Jiaotong University, focusing on tumor microenvironment-triggered therapeutic platforms. With an M.D. in Physical Chemistry from South China University of Technology and a Bachelor’s in Applied Chemistry from Jiujiang University, Dr. Jin’s expertise spans theranostics and polymer-based drug delivery. As a Principal Investigator, he has led multiple nationally funded projects, developing targeted nanomedicine strategies for liver cancer treatment. His pioneering work in self-delivery nanomedicine and combined chemotherapy approaches has earned him recognition in the scientific community, making significant contributions to personalized cancer treatment and molecular-targeted therapies.

🌍 Professional Profile:

Orcid

Scopus

🏆 Suitability for the Best Researcher Award

Dr. Ronghua Jin’s groundbreaking research in nanomedicine and cancer therapy makes him an outstanding candidate for the Best Researcher Award. His expertise in drug delivery systems and theranostics has led to innovative advancements, including esterase-responsive polymer prodrug delivery and self-delivery nanomedicine. As a Principal Investigator of multiple national and institutional research grants, he has secured significant funding to develop targeted therapies for liver cancer. His work bridges chemistry, nanotechnology, and medicine, enhancing the effectiveness of chemotherapeutic and sonodynamic treatments. With a strong publication record and notable contributions to molecular-targeted cancer therapies, Dr. Jin exemplifies excellence in research, making him highly deserving of this prestigious award.

🎓 Education 

Dr. Ronghua Jin holds a Ph.D. in Chemical Engineering from Xi’an Jiaotong University (2016–2019), where he developed tumor microenvironment-triggered multimodal therapeutic platforms under the mentorship of Prof. Xin Chen. He earned his M.D. in Physical Chemistry from South China University of Technology (2008–2011), focusing on ionic liquid-assisted extraction of active pharmaceutical compounds, advised by Prof. Xiaoning An. His academic journey began with a Bachelor’s in Applied Chemistry from Jiujiang University (2004–2008), where he built a strong foundation in chemical applications for medicinal research. His interdisciplinary education has enabled him to integrate chemistry, nanotechnology, and biomedical sciences to develop novel drug delivery and cancer therapy systems.

🏢 Research Experience 

Dr. Ronghua Jin has extensive research experience in nanomedicine, polymer drug delivery, and cancer therapy. As a Principal Investigator, he has led multiple research projects, including a National Natural Science Foundation of China (NSFC) project (CNY 320,000) on esterase-responsive polymer prodrug delivery for liver cancer therapy. He is also leading a High-Level Talent Project at Guangxi Medical University (CNY 200,000) and a Traditional Chinese Medicine molecular biology research project (CNY 30,000). His work focuses on self-delivery nanomedicine, combining chemotherapy and sonodynamic therapy for targeted liver cancer treatment. His expertise in nanotechnology-driven drug delivery platforms has significantly contributed to advancing personalized medicine and molecular-targeted cancer therapies.

🏅 Awards and Honors

Dr. Ronghua Jin has received several prestigious research grants and honors for his innovative contributions to nanomedicine and drug delivery systems. He is a Principal Investigator on multiple national and institutional research projects, securing funding from NSFC, Guangxi Medical University, and Traditional Chinese Medicine Treatment Research Programs. His work on esterase-responsive polymer prodrug delivery and self-delivery nanomedicine has been recognized for its breakthrough potential in liver cancer treatment. Dr. Jin has been invited to present his findings at leading international conferences, and his research has been published in top-tier journals. His contributions to theranostics, cancer therapy, and nanomedicine make him a highly respected figure in the field.

🔬 Research Focus 

Dr. Ronghua Jin’s research specializes in nanomedicine, drug delivery systems, cancer therapy, and theranostics. His work integrates chemistry, biomedical engineering, and nanotechnology to develop targeted therapies for liver cancer. A key focus is on esterase-responsive polymer prodrug delivery, enhancing chemotherapy and sonodynamic treatments. He is also pioneering self-delivery nanomedicine, enabling drugs to actively transport and target cancer cells without external carriers. His research aims to improve the efficiency and precision of drug delivery, reducing side effects and enhancing treatment outcomes. Through his work, he contributes to the advancement of personalized medicine, molecular-targeted therapies, and multi-modal cancer treatment strategies.

📊 Publication Top Notes:

  1. Antibacterial, Nontoxic, Antifreezing, and Self-Adhesive Conductive Eutectogel for Strain Sensor

    • Year: 2025

  1. Amelioration of Osteoarthritis through Salicylic Acid Nano-Formulated Self-Therapeutic Prodrug

    • Year: 2024

  2. T Cell-Depleting Nanoparticles Ameliorate Bone Loss by Reducing Activated T Cells and Regulating the Treg/Th17 Balance

    • Year: 2021

  3. Multifunctional Hierarchical Nanohybrids Perform Triple Antitumor Theranostics in a Cascaded Manner for Effective Tumor Treatment

    • Year: 2021

  1. 2D PtS Nanorectangles/g-C₃N₄ Nanosheets with a Metal Sulfide–Support Interaction Effect for High-Efficiency Photocatalytic H₂ Evolution

    • Year: 2021

 

 

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova, Medical University of Sofia, Bulgaria

Assoc. Prof. Dr. Marta Slavkova is an esteemed pharmaceutical researcher specializing in Pharmaceutical Technology and Biopharmacy. With a Ph.D. and ongoing specialization in Toxicology and Toxicological Analysis, she has made significant contributions to nanoparticulate drug delivery systems. Her research focuses on improving chemotherapeutics’ efficacy while reducing off-target effects. She has been a DAAD scholar in Düsseldorf, Germany, and has actively participated in international conferences. As a reviewer for WOS-indexed journals, she plays a crucial role in scientific advancements. Fluent in English and German, she teaches master’s students in Pharmaceutical Technology and continues to explore innovative drug delivery systems.

🌍 Professional Profile:

Google Scholar

Orcid

Scopus

🏆 Suitability for Best Researcher Award

Dr. Slavkova’s research in Medical and Pharmaceutical Technology, particularly in nanoparticulate drug delivery systems, showcases groundbreaking advancements in drug targeting and biopharmaceutical characterization. Her expertise in developing novel nanocarriers, including mesoporous silica and lipid-based nanoparticles, enhances therapeutic efficacy and safety. Her international collaborations, DAAD research scholarship, and extensive publication record make her a distinguished candidate for the Best Researcher Award. With hands-on experience in ISO quality standards, manuscript reviewing for WOS-indexed journals, and active participation in global conferences, Dr. Slavkova is an influential researcher dedicated to the progress of pharmaceutical sciences.

🎓 Education 

Dr. Slavkova earned her Ph.D. in Pharmaceutical Technology with a specialization in Biopharmacy. She is currently advancing her expertise in Toxicology and Toxicological Analysis. Her academic achievements include a DAAD scholarship for a 10-month research grant in Düsseldorf, Germany (2014-2015). Additionally, she has completed an auditor course in ISO 9001:2015 and ISO 19011:2018, equipping her with quality management expertise. Her extensive education and professional training allow her to bridge scientific research with industry standards. Fluent in English and German, she integrates international knowledge into her research and teaching, further strengthening her academic and professional profile.

👨‍🏫 Experience

Dr. Slavkova is an experienced researcher and academic, currently engaged in nanoparticulate drug delivery systems. She teaches Pharmaceutical Technology to master’s students and contributes significantly to pharmaceutical research. Her work includes developing novel drug carriers for parenteral, dermal, and oral applications, particularly for chemotherapeutics and natural bioactive compounds. She has participated in multiple international conferences, presenting her findings on improving drug efficacy and minimizing side effects. As a reviewer for WOS-indexed journals, she evaluates cutting-edge research, ensuring the highest quality standards. Her background in ISO auditing adds another layer of expertise to her scientific and professional endeavors.

🏅 Awards and Honors 

Dr. Slavkova has received numerous accolades for her contributions to pharmaceutical research. She was awarded a prestigious DAAD scholarship for a research grant in Düsseldorf, Germany (2014-2015). She has been an invited speaker at various international conferences, showcasing her expertise in nanoparticle drug delivery systems. Her active role as a reviewer for high-impact WOS-indexed journals highlights her influence in the scientific community. Additionally, she has been recognized for her contributions to pharmaceutical education, mentoring master’s students in advanced pharmaceutical technologies. Her interdisciplinary approach to drug delivery research has earned her recognition from both academic and industry professionals.

🔬 Research Focus 

Dr. Slavkova’s research revolves around nanoparticulate drug delivery systems, targeting various administration routes such as parenteral, dermal, and oral. She specializes in mesoporous silica nanoparticles, polymer nanoparticles, lipid nanocarriers, and hybrid nanoparticle systems. Her work aims to enhance chemotherapeutic efficacy while reducing systemic toxicity. Additionally, she investigates the biomedical potential of natural compounds like curcumin, quercetin, and berberine. Her expertise in biopharmaceutical characterization allows her to develop innovative drug targeting methods. With a strong focus on medical and pharmaceutical technology, her research contributes to the advancement of precision medicine and targeted therapies.

📖 Publication Top Notes

  • Orodispersible Drug Formulations for Children and Elderly

    • Year: 2015
    • Citations: 268
  • Gel Formulations for Topical Treatment of Skin Cancer: A Review

    • Year: 2023
    • Citations: 32
  • Superior Proapoptotic Activity of Curcumin-Loaded Mixed Block Copolymer Micelles with Mitochondrial Targeting Properties

    • Year: 2018
    • Citations: 21
  • A Novel Approach for Fabricating Nanocomposite Materials by Embedding Stabilized Core-Shell Micelles into Polysaccharide Cryogel Matrix

    • Year: 2018
    • Citations: 20
  • 10 Years EU Regulation of Pediatric Medicines–Impact on Cardiovascular Drug Formulations

    • Year: 2018
    • Citations: 14

 

 

Assist. Prof. Dr. Mila Kaleva | Medical Tech | Best Researcher Award

Assist. Prof. Dr. Mila Kaleva | Medical Tech | Best Researcher Award

Assist. Prof. Dr. Mila Kaleva, Stephan Angeloff Institute of Microbiology, Bulgaria

Assist. Prof. Dr. Mila Kaleva is a distinguished researcher in infectious microbiology, currently serving at “The Stephan Angeloff” Institute of Microbiology, Bulgarian Academy of Sciences. She earned her Ph.D. from the University of Forestry, Sofia, specializing in microbiological and epizootiological assessments of organic waste. With expertise in veterinary microbiology, infectious diseases, and food safety, Dr. Kaleva has contributed significantly to microbiology research and academia. She has extensive experience in laboratory research, teaching, and supervising students in veterinary microbiology. Her work focuses on advancing medical technology and veterinary pathology, ensuring improved disease control and food safety standards. 🦠🔬

🌍 Professional Profile:

Orcid

Google Scholar

🏆 Suitability for Award

Dr. Mila Kaleva is a highly accomplished researcher whose contributions to infectious microbiology and veterinary medicine make her an ideal candidate for the Best Researcher Award. Her work in microbial pathogen assessment, infectious disease control, and veterinary microbiology has significantly advanced scientific knowledge and public health. Through her research, she has developed innovative methodologies for handling organic waste in veterinary environments, enhancing disease prevention strategies. Her dedication to both research and teaching, coupled with her impactful publications, demonstrates her excellence in academia and applied science. This award would recognize her invaluable contributions to veterinary microbiology and infectious disease control. 🏆🔬

🎓 Education 

Dr. Mila Kaleva holds a Ph.D. in Infectious Pathology from the University of Forestry, Sofia, where she conducted research on microbiological and epizootiological assessments of organic waste in veterinary medicine. Prior to that, she obtained a Master’s degree in Veterinary Medicine from the same institution. Her academic training has provided her with deep expertise in microbiology, infectious diseases, and veterinary pathology. She has actively contributed to the field through advanced studies in disease control, medical technology, and food safety. Her education forms a strong foundation for her research in infectious microbiology, enabling her to pioneer new scientific advancements. 🎓🔬

🔬 Experience 

Dr. Kaleva has a rich professional background in microbiology research and veterinary medicine. Since 2019, she has been an Assistant Professor at “The Stephan Angeloff” Institute of Microbiology, specializing in infectious microbiology. She has also taught microbiology at the University of Forestry’s Faculty of Veterinary Medicine, mentoring students in laboratory research and applied microbiology. Her experience extends to laboratory-based pathogen analysis, disease prevention, and organic waste treatment in veterinary environments. Dr. Kaleva’s combined expertise in research and education allows her to contribute significantly to microbiological advancements while shaping the next generation of veterinary microbiologists. 🏥🔬

🏅 Awards and Honors 

Dr. Mila Kaleva has been recognized for her outstanding contributions to infectious microbiology and veterinary medicine. She has received research grants supporting her studies on pathogen control and organic waste management. Her work in veterinary microbiology has earned accolades from academic institutions and professional organizations. Additionally, she has participated in national and international conferences, presenting groundbreaking findings in microbiology and epizootiology. Her dedication to scientific excellence and innovative approaches to disease prevention have positioned her as a leader in her field. Dr. Kaleva’s achievements highlight her impact on veterinary medicine and infectious disease research. 🏅🔬

🔬 Research Focus

Dr. Mila Kaleva’s research revolves around infectious microbiology, veterinary medicine, and disease control. Her work explores microbiological assessments of organic waste, pathogen control in veterinary environments, and food safety regulations. She specializes in medical technology, focusing on veterinary pathology and epizootiological studies. Her studies contribute to understanding disease transmission, improving veterinary health, and developing advanced microbiological techniques. She is particularly interested in innovative solutions for mitigating microbial contamination in animal-origin food products. Her research plays a vital role in safeguarding public health by preventing the spread of infectious diseases in veterinary and agricultural sectors. 🔬🦠

📖 Publication Top Notes 

  • Cytotoxicity and Microbicidal Activity of Commonly Used Organic Solvents: A Comparative Study and Application to a Standardized Extract from Vaccinium macrocarpon
    • Year: 2021
    • Citations: 37
  • Antimicrobial and Antioxidant Potential of Scenedesmus obliquus Microalgae in the Context of Integral Biorefinery Concept
    • Citations: 31
  • Antimicrobial Effect in vitro of Aqueous Extracts of Leaves and Branches of Willow (Salix babylonica L.)
    • Year: 2015
    • Citations: 25
  • Decontamination of Sewage Sludge by Treatment with Calcium Oxide
    • Year: 2014
    • Citations: 18
  • Outstanding Antibacterial Activity of Hypericum rochelii—Comparison of the Antimicrobial Effects of Extracts and Fractions from Four Hypericum Species Growing in Bulgaria
    • Year: 2023
    • Citations: 13